title: Next-generation sequencing of urologic cancers: next is now.
abstract: The exomes/genomes of a few hundred kidney, bladder, and prostate tumours have been sequenced. This sequencing has unveiled new genes that are altered and new opportunities for tumour subclassification, prediction of outcome, and therapy. These opportunities will soon become realities.
authors.affiliation: Epithelial Carcinogenesis Group, CNIO-Spanish National Cancer Research Center, Madrid, Spain; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: preal@cnio.es.
authors.forename: Francisco X
authors.initials: FX
authors.lastname: Real
authors.affiliation: Ontario Institute for Cancer Research, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
authors.forename: Paul C
authors.initials: PC
authors.lastname: Boutros
authors.affiliation: Genetic and Molecular Epidemiology Group, CNIO-Spanish National Cancer Research Center, Madrid, Spain.
authors.forename: Núria
authors.initials: N
authors.lastname: Malats
mesh_terms: D002292:Carcinoma, Renal Cell / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods*; D004273:DNA, Neoplasm / Q000032:analysis*; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics*; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics*; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
chemical_list: D004273:DNA, Neoplasm